Previous Page  7 / 14 Next Page
Information
Show Menu
Previous Page 7 / 14 Next Page
Page Background

Page 22

Notes:

allied

academies

Curr Trend Cardiol. 2017 | Volume 1 Issue 3

September 18-19, 2017 | Toronto, Canada

Annual Conference on

HEART DISEASES

E

xtracorporeal membrane oxygenation is utilized for

providing both cardiac and respiratory support to heart

and lungs for mantainence of adequate gas exchange to

sustain life. Its main use is in children and adults with

advanced respiratory failure like hypercapnaeic respiratory

failure with an arterial pH of less than 7.20., in refractory

cardiogenic shock, advanced heart failure, cardiac arrest and

as a bridge to either cardiac transplantation or placement

of a VAD with improved survival rates in these situations.

Veno-Venous type of ECMO is used for Respiratory failure

and Veno-Arterial type of cardiac failure. In general VA

ECMO trials are shorter than V-V trials because of higher risk

of thrombus formation in the former. Major complications

of ECMO are neurological injury, life threatening bleeding,

heparin induced thrombocytopenia (HIT) and problems

during cannulation. Its relative contraindications are

conditions incompatible with normal life if the person

recovers and futility in those who are too sick.

Speaker Biography

Adarsh Kumar has been Professor & Head of cardiology department in GMC Amritsar

(India) for the last about 25 years with main field of Research in heart failure and

CAD. Has published more than 80 Research papers in different International /National

conferences all over the world. Ex President of International college of Cardiology.

Awarded gold medal for outstanding work/research in Cardiology all over the world by

Health Minister, Govt. of India.

e:

dradarshkumar1311@gmail.com

Role of ECMO as advanced life care support in end stage heart disease

Adarsh Kumar

Government Medical College, India